Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Biliary Stents Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The biliary stents market has seen strong growth in recent years. Its value is projected to increase from $0.5 billion in 2025 to $0.53 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. This historical expansion was driven by a limited variety of stent materials, a reliance on traditional plastic stents, a rising incidence of biliary obstructions, an increase in hospital-based procedures, and a lack of advanced endoscopic equipment.
The biliary stents market size is projected to experience substantial growth over the coming years, with an anticipated increase to $0.66 billion in 2030, achieving a compound annual growth rate (CAGR) of 5.6%. This expansion during the forecast period is driven by factors such as the development of covered and partially covered metal stents, a rising demand for biodegradable polymer stents, the increasing prevalence of minimally invasive surgical procedures, greater awareness of stent-related complications, and the integration of imaging and smart stent technologies. Significant trends for the forecast period include the growing use of self-expandable metal stents (sems), an uptick in the adoption of biodegradable polymer stents, a surge in endoscopic and minimally invasive procedures, the broadening of biliary stent applications for pancreatic and gallstone treatments, and an increased focus on stent safety and patient outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Biliary Stents Market Industry Drivers: What’s Behind The Revenue Growth?
An anticipated increase in pancreatic cancer cases is poised to drive expansion in the biliary stents market moving ahead. This condition describes a malignancy originating in the pancreatic tissues, a vital organ for digestion and blood glucose control. The increasing occurrence of pancreatic cancer is primarily attributable to an aging populace coupled with the growing prevalence of risk elements like obesity, diabetes, and tobacco use. Biliary stents play a crucial role in managing pancreatic cancer by alleviating blockages in the bile duct, enhancing hepatic function, and diminishing jaundice. These devices contribute to patient well-being through promoting superior bile flow, enabling uninterrupted cancer therapy, and elevating the overall quality of life. As an illustration, in February 2025, data from Cancer Australia, an Australian government body, indicated 4,641 new pancreatic cancer diagnoses in 2024, comprising 2,414 in males and 2,227 in females. Consequently, the escalating incidence of pancreatic cancer is fueling expansion within the biliary stents market.
Biliary Stents Market Segmentation And Category Overview
The biliary stents market covered in this report is segmented –
1) By Type: Metal, Polymer, Plastic
2) By Design: Single Stent, Double Stent, Triple Stent
3) By Procedure: Endoscopic Retrograde Cholangiopancreatography, Percutaneous Transhepatic Cholangiography
4) By Application: Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Structures, Gallstones, Other Applications
5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty clinics, Other End-Users
Subsegments:
1) By Metal: Self-Expandable Metal Stents (SEMS), Covered Metal Stents, Uncovered Metal Stents, Partially Covered Metal Stents
2) By Polymer: Biodegradable Polymer Stents, Non-Biodegradable Polymer Stents
3) By Plastic: Straight Plastic Stents, Double Pigtail Plastic Stents, Multiple Side Hole Stents, Teflon Stents, Polyurethane Stents
#Biliary Stents Market Growth Trends: What’s Shaping The Future Outlook?
Major companies in the biliary stents market are concentrating on developing advanced products, including drug-eluting stents, to improve patient outcomes, enhance durability, and minimize complications such as restenosis. Drug-eluting stents are specialized biliary stents that feature a medication coating slowly released to prevent tissue overgrowth and blockages in the bile ducts. For instance, in July 2024, CGBIO, a medical device company based in South Korea, obtained Pharmaceuticals and Medical Devices Agency (PMDA) approval in Japan for its biliary ARISTENT. This stent is engineered to treat bile duct blockages and incorporates a patented ‘HOOK & CROSS’ structure for superior flexibility and long-term patency. The ARISTENT adapts to the bile duct’s anatomy, which helps reduce migration risk and enhance patient comfort. Furthermore, it includes an advanced drug-eluting coating designed to minimize inflammation and prolong stent patency, thereby offering a more effective solution for biliary obstructions.
Biliary Stents Market Company Landscape And Competitive Strategy
Major companies operating in the biliary stents market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Becton Dickinson & Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Smith & Nephew Plc., W. L. Gore & Associates Inc., Nipro Corporation, Teleflex Incorporated, Cook Group, NuVasive Inc., Merit Medical Systems Inc., CONMED Corporation, Brainlab, Bard Peripheral Vascular Inc., Argon Medical Devices Inc., B Braun Melsungen AG, M.I Tech
View The Full Biliary Stents Market Report:
Biliary Stents Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the biliary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biliary stents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
